Citations to this article

Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines.
S Ramakrishnan, … , R C Bast Jr, E L Brown
S Ramakrishnan, … , R C Bast Jr, E L Brown
Published March 1, 1989
Citation Information: J Clin Invest. 1989;83(3):921-926. https://doi.org/10.1172/JCI113977.
View: Text | PDF
Research Article

Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines.

Abstract

Many nonhematologic tumors produce growth factors that may influence cellular proliferation either by autocrine or by paracrine mechanisms. In the current study, human tumor cell lines were investigated for the constitutive production of macrophage colony-stimulating factor (M-CSF). Culture supernatants obtained from cell lines were analyzed using a radioimmunoassay and a radioreceptor assay specific for M-CSF. Among the various cell types analyzed, all the ovarian cell lines and a majority of the breast cancer cell lines secreted significant amount of an M-CSF-like factor. Treatment of mouse bone marrow cultures with culture supernatants from ovarian cancer cells stimulated the production of macrophage colonies. Analysis of total cellular RNA obtained from the ovarian cell lines by Northern blot showed multiple sizes of M-CSF transcripts with an abundance of a 4.2-kb message. The relative amount of M-CSF transcripts correlated with the level of immunoreactive material seen in the culture supernatants.

Authors

S Ramakrishnan, F J Xu, S J Brandt, J E Niedel, R C Bast Jr, E L Brown

×

Total citations by year

Year: 2019 2018 2015 2014 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 Total
Citations: 2 2 1 2 4 1 2 1 4 1 1 6 2 2 6 2 2 5 4 8 4 12 9 8 10 3 104
Citation information

Citations to this article (104)

Title and authors Publication Year
CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages
A Ramesh, S Kumar, D Nandi, A Kulkarni 		Advanced materials (Deerfield Beach, Fla.) 2019
CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
WC Hsu, YC Lee, PI Liang, LL Chang, AM Huang, HH Lin, WJ Wu, CC Li, WM Li, JH Jhan, HL Ke 		Disease Markers 2019
The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer
S Savant, S Sriramkumar, H OHagan 		Cancers 2018
Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy
Y Morizawa, M Miyake, K Shimada, S Hori, Y Tatsumi, Y Nakai, N Tanaka, T Fujii, K Fujimoto 		Research and Reports in Urology 2018
Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells
A Arina, V Bronte 		Current Opinion in Immunology 2015
Macrophage colony-stimulating factor and cancer: a review
S Chockalingam, SS Ghosh 		Tumor Biology 2014
Bioenergetic Analysis of Ovarian Cancer Cell Lines: Profiling of Histological Subtypes and Identification of a Mitochondria-Defective Cell Line
U Dier, DH Shin, LP Hemachandra, LM Uusitalo, N Hempel, J Zhang 		PloS one 2014
Gynecologic Oncology
A Vasilev, S Vasilev 		Gynecologic Oncology 2011
Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma
DS Cho, SJ Kim, SH Lee, HS Ahn, YS Kim, SI Kim 		Korean Journal of Urology 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken 		Advances in Cancer Research Volume 110 2011
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines
A Morandi, V Barbetti, M Riverso, PD Sbarba, E Rovida 		PloS one 2011
Emerging Therapeutic Targets in Ovarian Cancer
S Kaye, R Brown, H Gabra, M Gore 		2010
Role of CSF-1 in progression of epithelial ovarian cancer
SK Chambers 		Future Oncology 2009
Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factor
L Ge, JG Zhang, CA Samathanam, C Delgado, M Tarbiyat-Boldaji, Q Dan, N Hoa, TV Nguyen, R Alipanah, JT Pham, R Sanchez, HT Wepsic, TR Morgan, MR Jadus 		Cellular Immunology 2009
Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies
TG Douglass, L Driggers, JG Zhang, N Hoa, C Delgado, CC Williams, Q Dan, R Sanchez, EW Jeffes, HT Wepsic, MP Myers, K Koths, MR Jadus 		International Immunopharmacology 2008
Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200
A Siva, H Xin, F Qin, D Oltean, KS Bowdish, A Kretz-Rommel 		Cancer Immunology, Immunotherapy 2007
Human monocytes kill M-CSF-expressing glioma cells by BK channel activation
NT Hoa, JG Zhang, CL Delgado, MP Myers, LL Callahan, G Vandeusen, PM Schiltz, HT Wepsic, MR Jadus 		Laboratory Investigation 2007
Peritoneal Fluid Cytokines and the Differential Diagnosis of Benign and Malignant Ovarian Tumors and Residual/Recurrent Disease Examination
M Chechlinska, J Kaminska, J Markowska, A Kramar, J Steffen 		The International Journal of Biological Markers 2007
Epithelial Ovarian Cancer: Disease Etiology, Treatment, Detection, and Investigational Gene, Metabolite, and Protein Biomarkers
TI Williams, KL Toups, DA Saggese, KR Kalli, WA Cliby, DC Muddiman 		Journal of Proteome Research 2007
Effects of Histologic Type on Levels of Macrophage Colony-Stimulating Factor in Liquid Contents of Benign Ovarian Tumors
M Hayashi, M Shibazaki, R Sohma, N Inaba 		The American Journal of the Medical Sciences 2006
Macrophage colony-stimulating factor expression in retrovirally transduced cells is dependent upon both the adherence status of the target cells and its 5′ flanking untranslated region
JG Zhang, Q Dan, TC Fong, CC Williams, MD Avina, M Tarbiyat-Boldaji, S Khalaghizadeh, M Irwin, A Nguyen, JL Zhuang, N Hoa, HT Wepsic, MR Jadus 		Biochemical and Biophysical Research Communications 2005
Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes
EM Neidhardt-Berard, F Berard, J Banchereau, AK Palucka 		Breast Cancer Research 2004
Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma1 1No competing interests declared
H Shimada, G Oohira, S Okazumi, H Matsubara, Y Nabeya, H Hayashi, A Takeda, Y Gunji, T Ochiai 		Journal of the American College of Surgeons 2004
Diagnosis and Management of Ovarian Disorders
AB Copperman, T Mukherjee, NG Kase 		Diagnosis and Management of Ovarian Disorders 2004
cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model
HM Kluger, Y Kluger, M Gilmore-Hebert, K DiVito, JT Chang, S Rodov, O Mironenko, BM Kacinski, AS Perkins, E Sapi 		Laboratory Investigation 2004
The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update
E Sapi 		Experimental biology and medicine (Maywood, N.J.) 2004
Macrophage Colony-Stimulating Factor-1 Receptor Expression Is Associated with Poor Outcome in Breast Cancer by Large Cohort Tissue Microarray Analysis
HM Kluger, M Dolled-Filhart, S Rodov, BM Kacinski, RL Camp, DL Rimm 		Clinical cancer research 2004
Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis
JL Yu, JW Rak 		Breast Cancer Research 2003
Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis
JL Yu, JW Rak 		Breast Cancer Research 2003
Tumor-associated macrophages: a molecular perspective
A Sica, A Saccani, A Mantovani 		International Immunopharmacology 2002
The macrophage growth factor CSF-1 in mammary gland development and tumor progression
Elaine Y Lin, Valerie Gouon-Evans, Andrew V Nguyen, Jeffrey W Pollard 		Journal of Mammary Gland Biology and Neoplasia 2002
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma
C Haaften-Day, Y Shen, F Xu, Y Yu, A Berchuck, LJ Havrilesky, HW de Bruijn, AG van der Zee, RC Bast, NF Hacker 		Cancer 2001
Ovarian fibrosarcoma producing multiple cytokines
T Fukuda, T Yamaguchi, T Yamaki, T Suzuki 		Pathology International 2001
Breast Cancer Increases Osteoclastogenesis by Secreting M-CSF and Upregulating RANKL in Stromal Cells
AT Mancino, VS Klimberg, M Yamamoto, SC Manolagas, E Abe 		Journal of Surgical Research 2001
Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor
Q Dan, H Trinh, CC Williams, C Lloyd, HT Wepsic, EW Jeffes, MR Jadus 		International Immunopharmacology 2001
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: A critical appraisal
C Haaften-Day, Y Shen, F Xu, Y Yu, A Berchuck, LJ Havrilesky, HW de Bruijn, AG van der Zee, RC Bast, NF Hacker 		Cancer 2001
Membrane Macrophage Colony-Stimulating Factor on MADB106 Breast Cancer Cells Does Not Activate Cytotoxic Macrophages but Immunizes Rats against Breast Cancer
CC Williams, H Trinh, TV Tran, Q Dan, R Sanchez, C Delgado, Y Chen, B Sippel, EW Jeffes, HT Wepsic, MR Jadus 		Molecular Therapy 2001
Tumour markers and ovarian cancer screening
B Kumar, J Davies-Humphreys 		The Obstetrician & Gynaecologist 2000
Macrophage-colony stimulating factor inhibits the growth of human ovarian cancer cells in vitro
Y Kawakami, N Nagai, K Ohama, K Zeki, Y Yoshida, E Kuroda, U Yamashita 		European Journal of Cancer 2000
The Role of Cytokines and Chemokines on Tumor Progression: A Review
SK Ardestani, P Inserra, D Solkoff, RR Watson 		Cancer Detection & Prevention 1999
Overexpression of Macrophage Colony-Stimulating Factor (CSF-I) and Its Receptor, c-fms, in Normal Ovarian Granulosa Cells Leads to Cell Proliferation and Tumorigenesis
N Keshava, S Gubba, RR Tekmal 		Journal of the Society for Gynecologic Investigation 1999
Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines
DM Savarese, H Valinski, P Quesenberry, T Savarese 		The Prostate 1998
Serum Macrophage Colony-Stimulating Factor (M-CSF) Levels in Patients with Epithelial Ovarian Cancer
A Gadducci, M Ferdeghini, C Castellani, C Annicchiarico, C Prontera, V Facchini, R Bianchi, AR Genazzani 		Gynecologic Oncology 1998
Le macrophage colony-stimulating factor
I Deneux 		Immuno-analyse & Biologie Spécialisée 1998
Paclitaxel (Taxol)-induced Gene Expression and Cell Death Are Both Mediated by the Activation of c-Jun NH 2 -terminal Kinase (JNK/SAPK)
LF Lee, G Li, DJ Templeton, JP Ting 		The Journal of biological chemistry 1998
Expression of CSF-I and CSF-I Receptor by Normal Lactating Mammary Epithelial Cells
E Sapi, MB Flick, S Rodoy, D Carter, BM Kacinski 		Journal of the Society for Gynecologic Investigation 1998
Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter
LF Lee, JS Haskill, N Mukaida, K Matsushima, JP Ting 		Molecular and cellular biology 1997
Expression of plasminogen activator inhibitor-2 in epithelial ovarian cancer: A favorable prognostic factor related to the actions of CSF-1
SK Chambers, CM Ivins, ML Carcangiu 		International Journal of Cancer 1997
Growth factors in human ovarian cancer
AM Westermann, JH Beijnen, WH Moolenaar, S Rodenhuis 		Cancer Treatment Reviews 1997
Tumour-derived, endocrine, exogenous and therapeutic factors differentially modulate cytokine secretion in whole blood cell culture
JR Fischer, M Schindel, H Lahm, P Drings 		European Journal of Cancer 1997
Cytokines in the ovary: Pathophysiology and potential for pharmacological intervention
RJ Norman, M Brännström 		Pharmacology & Therapeutics 1996
Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines
R Clarke 		Breast Cancer Research and Treatment 1996
Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer
G Olt, J Soper, S Ramakrishnan, F Xu, A Berchuck, D Clarke-Pearson, R Dodge, RC Bast 		American Journal of Obstetrics and Gynecology 1996
Prevention of postoperative adhesions by an antibody to vascular permeability factor/vascular endothelial growth factor in a murine model
AK Saltzman, TA Olson, D Mohanraj, LF Carson, S Ramakrishnan 		American Journal of Obstetrics and Gynecology 1996
Growth modulatory effects of granulocyte-macrophage colony-stimulating factor on human cell lines derived from gynecologic malignancies
TJ Herzog, TK Horiuchi, S Williams, HM Camel, DG Mutch 		American Journal of Obstetrics and Gynecology 1996
Molecular, Cellular, and Clinical Aspects of Angiogenesis
ME Maragoudakis 		1996
Cytokines in tumour growth, migration and metastasis
RP Negus, FR Balkwill 		World Journal of Urology 1996
Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study
SM Scholl, R Lidereau, A de la Rochefordière, CC Le-Nir, V Mosseri, C Noguès, P Pouillart, ER Stanley 		Breast Cancer Research and Treatment 1996
CSF-1 and Its Receptor in Ovarian, Endometrial and Breast Cancer
BM Kacinski 		Annals of Medicine 1995
Binding of a CTF/NF1-Like Protein to the Mouse Colony-Stimulating Factor-1 Gene Promoter
BW Konicek, XL Xia, MA Harrington 		DNA and Cell Biology 1995
Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection
JS Berek, RC Bast 		Cancer 1995
Increased levels of laminin in ascitic fluid of patients with ovarian cancer
LJ Byers, JL Osborne, LF Carson, JR Carter, AF Haney, JB Weinberg, S Ramakrishnan 		Cancer Letters 1995
Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells
AL Veatch, LF Carson, S Ramakrishnan 		International Journal of Cancer 1994
Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer
SM Scholl, CH Bascou, V Mosseri, R Olivares, H Magdelenat, T Dorval, T Palangié, P Validire, P Pouillart, ER Stanley 		British Journal of Cancer 1994
Post-transcriptional regulation of c-fms proto-oncogene expression by dexamethasone and of CSF-1 in human breast carcinomas in vitro
SK Chambers, Y Wang, M Gilmore-Hebert, BM Kacinski 		Steroids 1994
Constitutive secretion of bioactive transforming growth factor β1 by small cell lung cancer cell lines
JR Fischer, H Darjes, H Lahm, M Schindel, P Drings, PH Krammer 		European Journal of Cancer 1994
Significance of thrombocytosis in patients with epithelial ovarian cancer
AG Zeimet, C Marth, E Müller-Holzner, G Daxenbichler, O Dapunt 		American Journal of Obstetrics and Gynecology 1994
Cytokine-induced modulation of tumor suppressor gene expression in ovarian cancer cells: Up-regulation of p53 gene expression and induction of apoptosis by tumor necrosis factor-α
WH Gotlieb, JM Watson, A Rezai, M Johnson, O Martínez-Maza, JS Berek 		American Journal of Obstetrics and Gynecology 1994
Levels of soluble interleukin-2 receptor-α are elevated in serum and ascitic fluid from epithelial ovarian cancer patients
JA Hurteau, HU Simon, C Kurman, L Rubin, GB Mills 		American Journal of Obstetrics and Gynecology 1994
Use of Insulin-like Growth Factor-I Gene Expression to Distinguish Between Breast and Ovarian Cancer
D Yee, JC Jackson, DD von Hoff, PM Ravdin 		The American Journal of the Medical Sciences 1994
Pathogenesis of Ovarian Cancers
A Berchuck, A Elbendary, L Havrilesky, GC Rodriguez, RC Bast 		Journal of the Society for Gynecologic Investigation 1994
Messenger RNA Decay of Macrophage Colony-Stimulating Factor in Hum a n Ovarian Carcinomas in Vitro
SK Chambers, BM Kacinski 		Journal of the Society for Gynecologic Investigation 1994
Ovarian Cancer 3
F Sharp, P Mason, T Blackett, J Berek 		1994
Autonomous expressions of cytokine genes by human lung cancer cells and their paracrine regulation.
Mizuno K, Sone S, Orino E, Nii A, Ogura T 		Japanese journal of cancer research : Gann 1994
Cell growth regulation in epithelial ovarian cancer
RC Bast, CM Boyer, I Jacobs, FJ Xu, S Wu, J Wiener, M Kohler, A Berchuck 		Cancer 1993
High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer
G Gastl, M Plante, CL Finstad, GY Wong, MG Federici, NH Bander, SC Rubin 		British Journal of Haematology 1993
Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer
MM Moradi, LF Carson, LB Twiggs, JB Weinberg, AF Haney, S Ramakrishnan 		Cancer 1993
The expression and biological activity of IL-2 receptor on a human pancreas cancer cell line
H Kawami, K Yoshida, Y Yamaguchi, T Saeki, T Toge 		Biotherapy 1993
Growth regulation and transformation of ovarian epithelium
A Berchuck, MF Kohler, MP Boente, GC Rodriguez, RS Whitaker, RC Bast 		Cancer 1993
Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival
FV Price, SK Chambers, JT Chambers, ML Carcangiu, PE Schwartz, EI Kohorn, ER Stanley, BM Kacinski 		American Journal of Obstetrics and Gynecology 1993
Peritoneal fluid: its relevance to the development of endometriosis**Supported in part by a basic research support grant from Eastern Virginia Medical School, Norfolk, Virginia, and a grant from the Southern Medical Association, Birmingham, Alabama
JW Ramey, DF Archer 		Fertility and Sterility 1993
Molecular and biological factors in the pathogenesis of ovarian cancer
JS Berek, O Martínez-Maza, T Hamilton, C Tropé, J Kaern, J Baak, GJ Rustin 		Annals of Oncology 1993
Tumour markers
GJ Rustin, ME van der Burg, JS Berek 		Annals of Oncology 1993
Stimulation of the metastatic properties of lewis-lung-carcinoma cells by autologous granulocyte-macrophage colony-stimulating factor
MR Young, Y Lozano, M Coogan, MA Wright, ME Young, JM Bagash 		International Journal of Cancer 1992
M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes?
R Tang, M Ojeda, P Pouillart, S Scholl, F Beuvon, V Mosseri 		Journal of Cellular Biochemistry 1992
Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers
WH Gotlieb, JS Abrams, JM Watson, TJ Velu, JS Berek, O Martínez-Maza 		Cytokine 1992
Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α
S Wu, K Rodabaugh, O Martinez-Maza, JM Watson, DS Silberstein, CM Boyer, WP Peters, JB Weinberg, JS Berek, RC Bast 		American Journal of Obstetrics and Gynecology 1992
Serum levels of macrophage colony-stimulating factor in patients with ovarian cancer undergoing second-look laparotomy
SA Elg, Y Yu, LF Carson, LL Adcock, LB Twiggs, KA Prem, S Ramakrishnan 		American Journal of Obstetrics and Gynecology 1992
Biologic and Immunologic Therapy of Ovarian Cancer
MA Bookman, JS Berek 		Hematology/Oncology Clinics of North America 1992
Oncogenes in Ovarian Cancer
A Berchuck, MF Kohler, RC Bast 		Hematology/Oncology Clinics of North America 1992
Interleukin-6 and renal cell cancer: Production, regulation, and growth effects
AS Koo, C Armstrong, B Bochner, T Shimabukuro, CL Tso, JB deKernion, A Belldegrun 		Cancer Immunology, Immunotherapy 1992
Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies
G Baiocchi, M Talpaz, JU Gutterman, R Kurzrock, JJ Kavanagh, JT Wharton 		Cancer 1991
Epithelial ovarian cancer: a cytokine propelled disease?
S Malik, F Balkwill 		British Journal of Cancer 1991
Coordinate elevation of serum markers in ovarian cancer but not in benign disease
RC Bast, S Knauf, A Epenetos, B Dhokia, L Daly, M Tanner, J Soper, W Creasman, S Gall, RC Knapp, VR Zurawski, J Schlom, DW Kufe, RE Ritts 		Cancer 1991
Dynorphin blocks opioid inhibition of macrophage-colony stimulating factor-induced proliferation of bone marrow cells
S Roy, HH Loh, NM Lee 		European Journal of Pharmacology 1991
Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow
S Roy, S Ramakrishnan, HH Loh, NM Lee 		European Journal of Pharmacology 1991
Increased serum levels of macrophage colony-stimulating factor in ovarian cancer
FJ Xu, S Ramakrishnan, L Daly, JT Soper, A Berchuck, D Clarke-Pearson, RC Bast 		American Journal of Obstetrics and Gynecology 1991
Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer
JS Berek, C Chung, K Kaldi, JM Watson, RM Knox, O Martínez-Maza 		American Journal of Obstetrics and Gynecology 1991
Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cells
G Cimoli, P Russo, G Billi, G L Mariani, E Rovini, M Venturini 		Japanese journal of cancer research : Gann 1991
Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells
MR Young, MA Wright, ME Young 		Cancer Immunology, Immunotherapy 1991
Human Granulocyte‐Macrophage Colony‐stimulating Factor Is a Growth Factor Active on Human Ovarian Cancer Cells
Cimoli G, Russo P, Billi G, Mariani GL, Rovini E, Marco M 		Japanese journal of cancer research : Gann 1991
Gynecologic tumor markers
GJ Olt, A Berchuck, RC Bast 		Seminars in Surgical Oncology 1990
Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1
BM Kacinski, D Carter, K Mittal, LD Yee, KA Scata, L Donofrio, SK Chambers, KI Wang, T Yang-Feng, LR Rohrschneider 		The American Journal of Pathology 1990
Myelopoiesis-associated suppressor-cell activity in mice with lewis lung carcinoma tumors: Interferon-γ plus tumor necrosis factor-α synergistically reduce suppressor cell activity
MR Young, ME Young, MA Wright 		International Journal of Cancer 1990

Advertisement